In fact, we hypothesize that most of the ∼3% of patients with HHT according to Curaçao criteria who are not found to have a mutation in ACVRL1, ENG, or SMAD4, have an undetected deep intronic mutation in ACVRL1 or ENG. The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.